Company / Cash per Share
TG Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.51
FY2025
5-year range
$0.51 / $2.13
FY2021-FY2025
Trend
-57.2%
vs FY2024
Sector context
#169 of 205
Health Care
What the data says
TG Therapeutics, Inc.'s cash per share of $0.51 is lower than 82% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.50 in FY2019 to $5.06 in FY2020.
Based on SEC 10-K filings.
0.51 in FY2025 with a 5-year CAGR of -36.9%.
Declined from $0.63 to $0.51 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -10.7%
- 5-Year CAGR
- -36.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 205This company $0.51 Sector average $72.93
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 57.2% year-over-year.
- Ranks #169 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.51 | -57.2% |
| FY2024 | $1.19 | +87.1% |
| FY2023 | $0.63 | -11.1% |
| FY2022 | $0.71 | -66.4% |
| FY2021 | $2.13 | -58.0% |
| FY2020 | $5.06 | +911.4% |
| FY2019 | $0.50 | -12.8% |
| FY2018 | $0.57 | -37.2% |
| FY2017 | $0.91 | +79.0% |
| FY2016 | $0.51 | -57.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026